Health News Roundup: U.S. coronavirus cases rise by over 60,000; Global coronavirus cases rise to more than 12 million and more

U.S. coronavirus cases rise by over 60,000, setting single-day record The United States reported more than 60,000 new COVID-19 cases on Wednesday, the biggest increase ever reported by a country in a single day, according to a Reuters tally.

Health News Roundup: U.S. coronavirus cases rise by over 60,000; Global coronavirus cases rise to more than 12 million and more
Representative image Image Credit: ANI

Following is a summary of current health news briefs.

U.S. coronavirus cases rise by over 60,000, setting single-day record

The United States reported more than 60,000 new COVID-19 cases on Wednesday, the biggest increase ever reported by a country in a single day, according to a Reuters tally. The United States faces a bleak summer with record-breaking infections and many states forced to close parts of the economy again, leaving some workers without a paycheck.

Global coronavirus cases rise to more than 12 million

Global coronavirus cases exceeded 12 million on Wednesday, according to a Reuters tally, as evidence mounts of the airborne spread of the disease that has killed more than half a million people in seven months. The number of cases is triple that of severe influenza illnesses recorded annually, according to the World Health Organization.

Worsening U.S. outbreak prompts tough actions as new coronavirus cases hit record

New Jersey adopted a stringent coronavirus face-mask order on Wednesday, and New York City unveiled a plan to allow public school students back into classrooms for just two or three days a week, as newly confirmed U.S. COVID-19 cases soared to a daily global record. Officials in New Jersey and New York, the hardest-hit states at the outset of the U.S. outbreak, are trying to preserve progress in curtailing spread of the virus in the face of a resurgence elsewhere across the country, especially the South and West.

With apps and remote medicine, Japan offers glimpse of doctor visits in post-corona era

The coronavirus crisis has prompted Japan to ease regulations on remote medical treatment, creating an opening for tech companies and offering a glimpse of the future of healthcare in the world's most rapidly ageing society. As coronavirus cases spiked in April, Japan temporarily eased restrictions on remote medical care, allowing doctors to conduct first-time visits online or by telephone and expanding the number of illnesses that can be treated remotely.

Mexico posts new case record to overtake Spain; official says virus 'slowing'

Mexico on Wednesday posted a fresh record for new coronavirus cases reported on a single day, with 6,995 infections, overtaking Spain to register the world's eighth highest case count, according to a Reuters tally. Despite the soaring figures, Mexico's coronavirus czar, Hugo Lopez-Gatell, said the pandemic was "slowing."

Potential COVID-19 vaccine not 'single solution' to pandemic, Johnson & Johnson CEO says

U.S. drugmaker Johnson & Johnson aims to begin clinical testing of its COVID-19 vaccine in the coming weeks and produce billions of doses in 2021, chief executive officer Alex Gorsky said on Wednesday but cautioned that it will take more than one vaccine to rein in the virus. Gorsky said it was a good thing other companies are experimenting with different approaches to vaccines, in part because different vaccines might work better in different groups of people.

Gilead begins testing inhalable form of remdesivir for COVID-19

Gilead Sciences Inc said on Wednesday it has started an early-stage study of its antiviral COVID-19 treatment remdesivir that can be inhaled, for use outside of hospitals. The company said the trial, which will enroll about 60 healthy Americans aged between 18 and 45, will test the drug particularly in those cases where the disease has not progressed to require hospitalization. (https://bit.ly/38G3Zup)

Special Report: Bolsonaro bets 'miraculous cure' for COVID-19 can save Brazil - and his life

Brazilian President Jair Bolsonaro has gone all-in on hydroxychloroquine to help his coronavirus-ravaged country beat COVID-19. He has pushed his government to make the malaria drug widely available and encouraged Brazilians to take it, both to prevent the disease and to treat it. Now the far-right populist is putting his convictions to the ultimate test: Bolsonaro on Tuesday announced that he had tested positive for the disease and was taking hydroxychloroquine.

China reports nine new coronavirus cases in mainland

China reported nine new coronavirus cases in the mainland for July 8, compared with seven a day earlier, the health authority said on Thursday. All of the new infections were imported cases, according to a statement by the National Health Commission.

Exclusive: EU secures potential COVID-19 drugs from Roche, Germany's Merck

The European Commission has struck deals with drugmakers Roche and Merck KGaA to secure supplies of experimental treatments for COVID-19, a Commission source told Reuters on Wednesday. The deals cover Roche's arthritis drug RoActemra and Merck's multiple sclerosis drug Rebif - both seen as potential COVID-19 therapies - and will secure supplies for any of the 27 European Union member states wanting to buy them, the source said.

Give Feedback

Use this form for editorial or site feedback. We usually reply within 2 to 3 working days.

By submitting, you agree that we may use your email address to respond.